SCHEMBL23383017

SCHEMBL23383017

CC1(OC(=O)c2ccccc2C(=O)OCC(F)(F)C(=O)O)CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN1A P35498 2/20 0.43
▸ SCN2A Q99250 2/20 0.43
▸ SCN3A Q9NY46 2/20 0.43
▸ TSHR P16473 7/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PDK2 Q15119 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23383018 0.99 SCN1A (0.42) SCN1ASCN2ASCN3ATSHRNPSR1
SCHEMBL23382487 0.86 MAPK1 (0.40) SCN1ASCN2ASCN3ANPSR1MEN1
SCHEMBL23382995 0.85 CYP19A1 (0.39) SCN1ASCN2ASCN3ANPSR1MEN1
SCHEMBL31077823 0.81 SCN1A (0.54) SCN1ASCN2ASCN3ATSHRALDH1A1
SCHEMBL3411398 0.81 SCN1A (0.54) SCN1ASCN2ASCN3ATSHRALDH1A1
SCHEMBL304215 0.79 SCN1A (0.52) SCN1ASCN2ASCN3ATSHRALDH1A1
SCHEMBL31192379 0.79 SCN1A (0.52) SCN1ASCN2ASCN3ATSHRALDH1A1
SCHEMBL23383176 0.79 SCN1A (0.43) SCN1ASCN2ASCN3ATSHRMEN1
SCHEMBL23382490 0.78 SCN1A (0.43) SCN1ASCN2ASCN3AMEN1KMT2A
SCHEMBL23382804 0.77 RARA (0.35) NPSR1MEN1KMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 SCN1A 1012/4885SCN2A 1220/4885SCN3A 1477/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 SCN1A 1012/4885SCN2A 1220/4885SCN3A 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback